Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | RARB | P10826 | 8/20 | 0.46 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.46 |
| ▸ | RARA | P10276 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2976660 | 1.00 | CYP2C9 (0.59) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL2976664 | 1.00 | CYP2C9 (0.59) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL9352218 | 1.00 | CYP2C9 (0.59) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL220859 | 0.99 | CYP2C9 (0.61) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL220860 | 0.99 | CYP2C9 (0.61) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL10832130 | 0.97 | CYP2C9 (0.59) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| Hydrochloric Acid SCHEMBL8556829 | 0.97 | CYP2C9 (0.59) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL10832120 | 0.97 | CYP2C9 (0.59) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| Hydrochloric Acid SCHEMBL8556826 | 0.97 | CYP2C9 (0.59) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL10832126 | 0.97 | CYP2C9 (0.59) | CYP2C9ALDH1A1MAPTLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104927879-B | Aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display element | JSR株式会社 | 2018-09-18 | — | — | CN | disclosed |
| US-9976085-B2 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | CHI MEI CORPORATION (TW) | 2018-05-22 | — | — | US | disclosed |
| CN-105969404-B | Liquid crystal aligning agent, liquid crystal alignment film formed by liquid crystal aligning agent and liquid crystal display element | 奇美实业股份有限公司 | 2018-03-23 | — | — | CN | disclosed |
| CN-105969404-A | Liquid crystal aligning agent, liquid crystal alignment film formed by liquid crystal aligning agent and liquid crystal display element | 奇美实业股份有限公司 | 2016-09-28 | — | — | CN | disclosed |
| CN-105567257-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2016-05-11 | — | — | CN | disclosed |
| US-20160122652-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | CHI MEI CORPORATION (TW) | 2016-05-05 | — | — | US | disclosed |
| CN-103571502-B | Crystal aligning agent and compound | JSR CO., LTD. (JP) | 2016-05-04 | — | — | CN | disclosed |
| CN-103374353-B | The manufacture method of crystal aligning agent, liquid crystal orienting film, liquid crystal display device and liquid crystal display device | JSR CO., LTD. (JP) | 2016-01-20 | — | — | CN | disclosed |
| US-20150337013-A1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | MERCK SHARP & DOHME CORP. (US) | 2015-11-26 | — | — | US | disclosed |
| CN-103131431-B | MATERIALS FOR DISPLAY, crystal aligning agent and liquid crystal display device | JSR CO., LTD. (JP) | 2015-10-07 | — | — | CN | disclosed |
| EP-2379580-B1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | CUBIST PHARM INC (US) | 2013-10-23 | — | — | EP | disclosed |
| CN-103320146-A | Liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element and method of making liquid crystal display element | JSR CORP | 2013-09-25 | — | — | CN | disclosed |
| US-8507647-B2 | Antibacterial agents for the treatment of gram positive infections | CUBIST PHARMACEUTICALS, INC. (US) | 2013-08-13 | — | — | US | disclosed |
| CN-103131431-A | Display material, liquid crystal alignment agent and liquid crystal display element | JSR CORP | 2013-06-05 | — | — | CN | disclosed |
| CN-102311739-A | The method of manufacture of liquid crystal aligning agent, liquid crystal display device and liquid crystal display device | JSR CORP | 2012-01-11 | — | — | CN | disclosed |
| CN-102236209-A | Producing method of liquid crystal display element, polymer composition and liquid crystal display element | JSR CORP | 2011-11-09 | — | — | CN | disclosed |
| EP-2379580-A1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | Cubist Pharmaceuticals, Inc. (US) | 2011-10-26 | — | — | EP | disclosed |
| CN-102053425-A | Liquid crystal display element manufacturing method , polymer composition and liquid crystal display element | JSR CORP | 2011-05-11 | — | — | CN | disclosed |
| US-20100184649-A1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | CUBIST PHARMACEUTICALS, INC. | 2010-07-22 | — | — | US | disclosed |
| WO-2010075215-A1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | CUBIST PHARMACEUTICALS, INC. (US) | 2010-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150337013-A1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | CLPP, CLPTM1, RPN1 | CYP2C9 4640/4885ALDH1A1 4703/4885MAPT 4574/4885 |
| US-20100184649-A1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | CLPP, CLPTM1, RPN1 | CYP2C9 4640/4885ALDH1A1 4703/4885MAPT 4574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.